EcoDrugPlus

Ensembl ID : ENSIPUG00000023261
Gene Symbol: -
Cross references: -
304 Possible Orthologues:

Ensembl ID : ENSIPUG00000011790
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSIPUG00000009123
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSIPUG00000022207
Gene Symbol: -
Cross references: -
66 Possible Orthologues:

Ensembl ID : ENSIPUG00000017329
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSIPUG00000023956
Gene Symbol: -
Cross references: -
122 Possible Orthologues:

Ensembl ID : ENSIPUG00000024298
Gene Symbol: -
Cross references: -
511 Possible Orthologues:

Ensembl ID : ENSIPUG00000013505
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSIPUG00000018966
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSIPUG00000001523
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSIPUG00000001616
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSIPUG00000004184
Gene Symbol: -
Cross references: -
157 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).